Effect of retinoic acid on murine preosteoblastic MC3T3-E1 cells

Journal of Nutritional Science and Vitaminology

Volumn 51, Issue 5, 2005, Pages 311-318

  Nagasawa, Hiroyuki ^a   Takahashi, Shu ^a   Kobayashi, Akira ^a   Tazawa, Hiroshi ^a   Tashima, Yohtalou ^a   Sato, Kozo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Osteoblast; Proliferation; Retinoic acid; Retinoid X receptor

Indexed keywords

ALITRETINOIN; ALKALINE PHOSPHATASE; HISTONE H4; LIGAND; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; RETINOIC ACID; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HETEROTOPIC OSSIFICATION; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; POSTERIOR LONGITUDINAL LIGAMENT; PROTEIN CONTENT;

ANIMALIA; MURINAE;

EID: 28444451824     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.51.311     Document Type: Article

References (46)

1. Nakayama Y, Takahashi K, Noji S, Muto K, Nishijima K, Taniguchi S. 1990. Functional models of retinoic acid in mouse osteoblastic clone MC3T3-E1, proved as a target cell for retinoic acid. FEBS Lett 261: 93-96.
2. Inoue A, Otuka E, Hiruma Y, Hirose S, Furuya M, Tanaka S, Hagiwara H. 1996. Stimulation by retinoids of the natriuretic peptide system of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 228: 182-186.
3. Wolbach SB. 1947. Vitamin-A deficiency and excess in relation to skeletal growth. J Bone Joint Surg 29: 171-192.
4. Saneshige S, Mano H, Tezuka K, Kakudo S, Mori Y, Honda Y, Itabashi A, Yamada T, Miyata K, Hakeda Y, Ishii J, Kumegawa M. 1995. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem J 309: 721-724.
5. DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL. 1986. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med 315: 1177-1182.
6. McGuire J, Lawson JP. 1987. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica 175: 169-181.
7. Breidahl P. 1969. Ossification of the posterior longitudinal ligament in the cervical spine. Aust Radiol 13: 311-313.
8. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S. 1997. Bone morphogenic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 60: 291-296.
9. Ishida Y, Kawai S. 1993. Characterization of cultured cells derived from ossification of the posterior longitudinal ligament of the spine. Bone 14: 85-91.
10. Gazit D, Ebner R, Kahn AJ, Derynck R. 1993. Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7: 189-198.
11. Seawright AA, English PB, Gartner RJW. 1965. Hypervitaminosis A and hyperostosis of the cat. Nature 206: 1171-1172.
12. Pennes DR, Martel W, Ellis CN. 1985. Retinoid-induced ossification of the posterior longitudinal ligament. Skeletal Radiol 14: 191-193.
13. DeBandt M, Meyer O, Fuster JM, Kahn MF. 1995. Ossification of the posterior longitudinal ligament, diffuse, idiopathic skeletal hyperostosis, abnormal retinol and retinol binding protein: a familial observation. J Rheumatol 22: 1395-1398.
14. Ishizawa N. 1992. Experimental study of hyperostosis induced by hyper-vitaminosis A. J Jpn Orthop Assoc 66: 919-930 (in Japanese).
15. Kudo T. 1995. Retinoic acid-induced hyperostosis in the murine spine, particularly in the cervical spine. J Jpn Orthop Assoc 69: 744-753 (in Japanese).
16. Koga H, Sakou T, Taketomi E, Hayashi K, Numasawa T, Harata S, Yone K, Matsunaga S, Otterud B, Inoue I, Leppert M. 1998. Genetic mapping of ossification of the posterior longitudinal ligament of the spine. Am J Hum Genet 62: 1460-1467.
17. Numasawa T, Koga H, Ueyama K, Maeda S, Sakou T, Harata S, Leppert M, Inoue I. 1999. Human retinoic X receptor β: Complete genomic sequence and mutation search for ossification of posterior longitudinal ligament of the spine. J Bone Miner Res 14: 500-508.
18. Vandenberg P, Vuoristo MM, Ala-Kokko L, Prockop DJ. 1996. The mouse col11a2 gene. Some transcripts from the adjacent rxr-β gene extend into the col11a2 gene. Matrix Biol 15: 359-367.
19. 3-activated expression of rat osteocalcin gene. Mol Cell Biol 13: 5907-5917.
20. 3 and inhibited by 9-cis-retinoic acid. J Biol Chem 273: 8483-8491.
21. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. 1992. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6: 329-344.
22. Kodama H, Amagai Y, Sudo H, Kasai S, Yamamoto S. 1981. Establishment of a clonal osteogenic cell line from newborn mouse calvaria. Jpn J Oral Biol 23: 899-901.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
24. Lowry OH, Roberts NR, Wu M, Hixon WS, Crawford EJ. 1954. The quantitative histochemistry of the brain II enzyme measurements. J Biol Chem 207: 19-37.
25. Benayabu D, Shamay A, Wientroub S. 1997. Osteocalcin (BGP) gene expression, and protein production by marrow stromal adipocytes. Biochem Biophys Res Commun 231: 442-446.
26. Tanji N, Yokoyama M, Takeuchi M, Terada N, Dahiya R, Cunha GR. 1996. Inhibitory effects of retinoic acids on androgen-dependent development of neonatal mouse seminal vesicles in vitro. Endocrinology 137: 2887-2895.
27. Arcari P, Martinelli R, Salvatore F. 1984. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12: 9179-9189.
28. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. 1990. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143: 213-221.
29. Park CK, Ishimi Y, Ohmura M, Yamaguchi M, Ikegami S. 1997. Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J Nutr Sci Vitaminol 43: 281-296.
30. Kaji H, Sugimoto T, Kanatani M, Kano J, Fukuse M, Chihara K. 1995. Effect of retinoic acid on the proliferation and alkaline phosphatase activity of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Exp Clin Endocrinol Diabetes 103: 297-302.
31. Glantschnig H, Varga F, Klaushofer K. 1996. Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor-binding protein-4 in mouse osteoblastic cells. Endocrinology 137: 281-286.
32. Iijima K, Sudo H, Amagi Y, Niida S, Itakura Y, Ohno T, Yamamoto S. 1987. Effects of ascorbic acid deficiency on differentiation of osteogenic MC3T3-E1 cells. J Tohoku Dental Univ 14: 52-56 (in Japanese).
33. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. 1991. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 1496-1504.
34. 3 and thyroid hormone in three osteosarcoma cell lines. Endocrinology 136: 4304-4314.
35. Yoon K, Buenaga R, Rodan GA. 1987. Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun 148: 1129-1136.
36. Oliva A, Ragione FD, Fratta M, Marrone G, Palumbo R, Zappia V. 1993. Effect of retinoic acid on osteocalcin gene expression in human osteoblasts. Biochem Biophys Res Commun 191: 908-914.
37. Ohishi K, Nishikawa S, Nagata T, Yamauchi N, Shinohara H, Kido J, Ishida H. 1995. Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro. Eur J Endocrinol 133: 335-341.
38. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87: 9995-9999.
39. Rahman S, Oberdolf A, Montecino M, Tanhauser SM, Lian JB, Stein GS, Laipis PJ, Stein JL. 1993. Multiple copies of the bone-specific osteocalcin in mouse and rat. Endocrinology 133: 3050-3053.
40. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406.
41. Sucov HM, Murakami KK, Evans RM. 1990. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc Natl Acad Sci USA 87: 5392-5396.
42. Melhus H, Gobl A, Ljunghall S. 1994. Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells. Biochem Biophys Res Commun 200: 1125-1129.
43. Mertz JR, Shang E, Piantedosi R, Wei S, Wolgemuth DJ, Blaner WS. 1997. Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. J Biol Chem 272: 11744-11749.
44. Romert A, Tuvendal P, Simon A, Dencker L, Erikoon U. 1998. The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid. Proc Natl Acad Sci USA 95: 4404-4409.
45. Murayama A, Suzuki T, Matsui M. 1997. Photoisomerization of retinoic acids in ethanol under the room light: A warning for cell biological study of geometrical isomers of retinoids. J Nutr Sci Vitaminol 43: 167-176.
46. Parker RS. 1996. Absorption, metabolism, and transport of carotenoids. FASEB J 10: 542-551.